In vitro activity of multiple antibiotic combinations against Nocardia: Relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis

Transplant Infectious Disease

Volumn 13, Issue 4, 2011, Pages 335-343

  Tripodi, M F ^a   Durante Mangoni, E ^a   Fortunato, R ^a   Cuccurullo, S ^a   Mikami, Y ^b   Farina, C ^c   Utili, R ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CHIBA UNIVERSITY   (Japan)

^c SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Antibacterial therapy; Bactericidal activity; Heart transplant; Nocardiosis; Time kill curves

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFAMANDOLE; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LINEZOLID; MEROPENEM; MOXIFLOXACIN; NETILMICIN; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; RIFAMPICIN; STREPTOMYCIN; SULBACTAM; SULTAMICILLIN; TOBRAMYCIN; UNINDEXED DRUG;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISK DIFFUSION; DRUG ACTIVITY; FEMALE; GRAFT RECIPIENT; HEART GRAFT; HUMAN; IN VITRO STUDY; LUNG INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NOCARDIA; NOCARDIOSIS; PRIORITY JOURNAL; SHORT COURSE THERAPY; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG THERAPY, COMBINATION; FEMALE; HEART TRANSPLANTATION; HUMANS; LUNG DISEASES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NOCARDIA; NOCARDIA INFECTIONS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79961176853     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00588.x     Document Type: Article

References (30)

1. Peleg AY, Husain S, Qureshi ZA, et al. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis 2007; 44 (10): 1307-1314.
2. Lederman ER, Crum NF. A case series and focused review of nocardiosis: clinical and microbiologic aspects. Medicine (Baltimore) 2004; 83 (5): 300-313.
3. Haddad F, Hunt SA, Perlroth M, et al. Pulmonary nocardiosis in a heart transplant patient: case report and review of the literature. J Heart Lung Transplant 2007; 26 (1): 93-97.
4. Husain S, McCurry K, Dauber J, et al. Nocardia infection in lung transplant recipients. J Heart Lung Transplant 2002; 21 (3): 354-359.
5. Khan BA, Duncan M, Reynolds J, et al. Nocardia infection in lung transplant recipients. Clin Transplant 2008; 22 (5): 562-566.
6. Peraira JR, Segovia J, Fuentes R, et al. Pulmonary nocardiosis in heart transplant recipients: treatment and outcome. Transplant Proc 2003; 35 (5): 2006-2008.
7. Poonyagariyagorn HK, Gershman A, Avery R, et al. Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients. Transpl Infect Dis 2008; 10 (6): 403-408.
8. Nocardia infections. Am J Transplant 2004; 4 (Suppl 10): 47-50.
9. Tripodi MF, Adinolfi LE, Andreana A, et al. Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies. Clin Transplant 2001; 15 (6): 415-420.
10. Brown-Elliott BA, Ward SC, Crist CJ, et al. In vitro activities of linezolid against multiple Nocardia species. Antimicrob Agents Chemother 2001; 45 (4): 1295-1297.
11. Moylett EH, Pacheco SE, Brown-Elliott BA, et al. Clinical experience with linezolid for the treatment of nocardia infection. Clin Infect Dis 2003; 36 (3): 313-318.
12. Glupczynski Y, Berhin C, Janssens M, et al. Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. Clin Microbiol Infect 2006; 12 (9): 905-912.
13. Gombert ME, Aulicino TM. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides. Antimicrob Agents Chemother 1983; 24 (5): 810-811.
14. Kanemitsu K, Kunishima H, Saga T, et al. Efficacy of amikacin combinations for nocardiosis. Tohoku J Exp Med 2003; 201 (3): 157-163.
15. Orfanakis MG, Wilcox HG, Smith CB. In vitro studies of the combined effect of ampicillin and sulfonamides on Nocardia asteroides and results of therapy in four patients. Antimicrob Agents Chemother 1972; 1 (3): 215-220.
16. Gordon RE, Barnett DA, Handerhan JE, et al. Nocardia coeliaca, Nocardia autotrophica, and the Nocardin Strain. Int J Syst Evol Microbiol 1974; 24 (1): 54-63.
17. Mishra SK, Gordon RE, Barnett DA. Identification of nocardiae and streptomycetes of medical importance. J Clin Microbiol 1980; 11 (6): 728-736.
18. Kageyama A, Yazawa K, Nishimura K, et al. Nocardia inohanensis sp. nov., Nocardia yamanashiensis sp. nov. and Nocardia niigatensis sp. nov., isolated from clinical specimens. Int J Syst Evol Microbiol 2004; 54 (Part 2): 563-569.
19. Miyadoh M. Identification procedure at the genus level. In: Miyadoh S, Hamada M, Hotta K, Kudo T, Seino A, Suzuki K, Yokota A, eds. Identification Manual of Actinomycetes. Tokyo: Business Center for Academic Societies, 2001: 9-19.
20. Woods GL, Brown-Elliott BA, Desmond EP, et al. Susceptibility testing of mycobacteria, nocardiae and other aerobic actinomycetes. In: NCCLS. Vol. M24-A, 3rd edn. Wayne, PA, USA: National Committee for Clinical Laboratory Standards, 2003.
21. Woods GL, Brown-Elliott BA, Desmond EP, et al. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; Twelfth Informational Supplement. M100-S12. Wayne, PA: NCCLS, 2002.
22. Tripodi MF, Utili R, Rambaldi A, et al. Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci. J Antimicrob Chemother 1996; 37 (4): 727-736.
23. Farina C, Andrini L, Bruno G, et al. Nocardia brasiliensis in Italy: a nine-year experience. Scand J Infect Dis 2007; 39 (11-12): 969-974.
24. Brown-Elliott BA, Brown JM, Conville PS, et al. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev 2006; 19 (2): 259-282.
25. Wauters G, Avesani V, Charlier J, et al. Distribution of nocardia species in clinical samples and their routine rapid identification in the laboratory. J Clin Microbiol 2005; 43 (6): 2624-2628.
26. Moellering RC Jr, Wennersten C, Weinberg AN. Studies on antibiotic synergism against enterococci. I. Bacteriologic studies. J Lab Clin Med 1971; 77 (5): 821-828.
27. Jacqueline C, Caillon J, Le Mabecque V, et al. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods. J Antimicrob Chemother 2003; 51 (4): 857-864.
28. Gombert ME, Berkowitz LB, Aulicino TM, et al. Therapy of pulmonary nocardiosis in immunocompromised mice. Antimicrob Agents Chemother 1990; 34 (9): 1766-1768.
29. Wallace RJ Jr, Septimus EJ, Musher DM, et al. Treatment of experimental nocardiosis in mice: comparison of amikacin and sulfonamide. J Infect Dis 1979; 140 (2): 244-248.
30. Hansen G, Swanzy S, Gupta R, et al. In vitro activity of fluoroquinolones against clinical isolates of Nocardia identified by partial 16S rRNA sequencing. Eur J Clin Microbiol Infect Dis 2008; 27 (2): 115-120.